Skip to the page

Data / Form D filings / Telesis Bio Inc.

Telesis Bio Inc.: Form D filing

Telesis Bio Inc., a health care company in San Diego, CA, filed a Form D with the SEC in 2023. The latest, on June 20, 2023, reports $28 million sold of a $74.2 million offering to 4 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
10431 Wateridge Circle, SUITE 150, San Diego, CA, 92121
Phone
(858) 228-4115
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
$25,000,001 - $100,000,000
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1850079

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 20, 2023New notice$74,200,000$28,000,000$46,200,0004Jun 5, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Franklin R. WitneyDirector
Eric H. EsserExecutive Officer
Paul V. MeisterDirector
William F. SniderDirector
Andrea L. JacksonDirector
Christine A. TsingosDirector
Robert H. CutlerExecutive Officer
Annette V. TumoloDirector
Jami A. NachtsheimDirector
Daniel G. GibsonExecutive Officer
Todd R. NelsonExecutive Officer, Director

Other health care companies in California that filed recently

Every Form D from the week of Jun 19, 2023 · All recent filings in California · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Telesis Bio Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.